22 results
8-K
EX-10.1
CKPT
Checkpoint Therapeutics Inc
30 Jan 24
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
5:00pm
certain deficiencies have been addressed as cited in the FDA Complete Response Letter the Company received in December 2023.
(ii) Cybersecurity. (i)(x
8-K
EX-10.1
ehbhhm1y6dktec3lu
31 Jul 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market
8:28am
8-K
EX-10.1
ms8zmz
24 May 23
Checkpoint Therapeutics Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
5:24pm
8-K
EX-10.1
pzap8ocknu 6n
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-10.1
r3x7mh2jr56ftu
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am